Stephanie Smith-Marrone, MD

Medical Oncology
More specialties
Accepting New Patients
Profile Headshot


Stephanie Smith-Marrone, MD, is board certified in oncology and an assistant professor of medicine at Columbia University Medical Center. She is also the director of the lung cancer disease management team and clinical trials at NewYork-Presbyterian Lawrence Hospital Cancer Center. Dr. Smith-Marrone specializes in medical oncology, lung cancer, and head and neck cancer. She offers her patients a personalized, supportive, and collaborative-care approach and works to improve their health by using scientific advances and individualized treatment options. Dr. Smith-Marrone completed her medical degree, internship, residency and chief residency at Stony Brook University Medical Center in New York. She continued her training by serving a fellowship in hematology and oncology at Montefiore Medical Center.

Areas of Expertise / Conditions Treated

  • Head and Neck Cancer
  • Lung Cancer
  • Oral Cancer

Academic Appointments

  • Assistant Professor of Medicine at CUMC

Hospital Affiliations

  • NewYork-Presbyterian Lawrence Hospital


  • Female

Schedule an Appointment

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In


55 Palmer Avenue
Bronxville, NY 10708

Insurance Accepted

1199 National Benefit Fund

  • 1199 National Benefit Fund


  • Aetna

Affinity Health Plan

  • Affinity

Amida Care

  • Amida Care

Anthem Blue Cross Blue Shield

  • Anthem Blue Cross Blue Shield


  • Cigna


  • Connecticare


  • Elderplan

Empire Blue Cross/Blue Shield

  • Empire Blue Cross Blue Shield

Fidelis Care

  • Fidelis Care


  • Healthfirst


  • Multiplan

MVP Health Care

  • MVP Health Care


  • Unicare


  • UnitedHealthcare




  • WellCare

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • Medical Doctor (MD), New York Presbyterian Hospital
  • Residency: 2005 SUNY Stony Brook University Hospital
  • Fellowship: 2008 Albert Einstein College of Medicine

Board Certifications

  • Medical Oncology


Dr. Smith-Marrone is currently the Director of Cancer Clinical Trials at NYP/Lawrence Hospital and also refers lung and head and neck cancer patients to clinical trials available through Herbert Irving Comprehensive Cancer Center at Columbia University.

Selected Publications

Susana Hernandez, Tiffany Negri, Adrian G. Sacher, Stephanie Smith-Marrone, Mark Stoopler, Justin F. Gainor, Mark M. Awad, Frank D'Ovidio, Joshua R. Sonett, Matthew Bacchetta, Anjali Saqi, Naiyer A. Rizvi; Columbia University Medical Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; Massachusetts General Hospital, Boston, MA; Massachusetts General Hospital, Cambridge, MA. "Neoadjuvant atezolizumab + chemotherapy in resectable non-small cell lung cancer (NSCLC)." J Clin Oncol 36, 2018 (suppl; abstr 8532)

M.C. Pietanza, MatthewD. Hellmann, John J. Fiore, Stephanie Smith-Marrone, Ethan M. Basch, Lawrence H. Schwartz, Michelle S. Ginsberg, Marwan Shouery, Samantha K. Newman, Mary Shaw, Lauren J. Rogak, Alex E. Lash, Patrick Hilden, Mark G. Kris, "Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas. J Thor Oncol. 2016; 11: 890-899.

Waldman, Abigail H., Jennifer M. Mcniff, Annmarie Liapakis, William S. Asch, Stephanie Smith-Marrone, and Oscar R. Colegio. Revision of Immunosuppression in a Solid Organ Transplant Recipient Leads to Complete Remission of Metastatic Undifferentiated Carcinoma." JAAD Case Reports 1.6 (2015): S8-S11.

Fury, M. G., Xiao, H., Sherman, E. J., Baxi, S., Smith-Marrone, S., Schupak, K., Gewanter, R., Gelblum, D., Haque, S., Schoder, H., Shah, J. P., Katabi, N., Kurtzman, R., Lipson, B., Cox, L., Lee, N. Y. and Pfister, D. G. (2015), Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma. Head Neck. doi: 10.1002/hed.24041

Gregory J. Riely, Helena Alexandra Yu, Dennis Stephens, Maria Catherine Pietanza, Stephanie Smith-Marrone, John Joseph Fiore, Melissa Goldstein, Camelia S. Sima, Mark G. Kris, and Michelle S. Ginsberg. A Phase I Study of Crizotinib and ganestespib (STA-9090) in ALK positive lung cancers. J Clin Oncol (Meeting Abstracts) May 2015 vol. 33 no. 15_suppl 8064.